Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer.
Ma L, Hernandez MO, Zhao Y, Mehta M, Tran B, Kelly M, Rae Z, Hernandez JM, Davis JL, Martin SP, Kleiner DE, Hewitt SM, Ylaya K, Wood BJ, Greten TF, Wang XW.
Cancer Cell. 2019 Oct 14;36(4):418-430.e6. doi: 10.1016/j.ccell.2019.08.007. Epub 2019 Oct 3.
Advances in targeted therapy of cholangiocarcinoma.
Li Y, Yu J, Zhang Y, Peng C, Song Y, Liu S.
Ann Med. 2024 Dec;56(1):2310196. doi: 10.1080/07853890.2024.2310196. Epub 2024 Feb 15.
TRENDS AND ALTERNATIVES IN TREATMENT OF MALIGNANT TUMORS OF EXTRAHEPATIC BILE DUCTS.
Stoyanov V, Dimitrova V.
Khirurgiia (Sofiia). 2015;81(3):149-60.
[Cholangiocarcinomas].
Schöning W, Haber PK, Pratschke J.
Chirurgie (Heidelb). 2025 Jan;96(1):77-86. doi: 10.1007/s00104-024-02200-z. Epub 2024 Dec 10.
[Cholangiocarcinoma].
Burgos San Juan L.
Rev Med Chil. 2008 Feb;136(2):240-8. Epub 2008 May 7.
Prevention of major biliary complications by fusion imaging for thermal ablation of malignant liver tumors adjacent to the bile ducts: a preliminary comparative study.
Liu J, Li L, Zeng Q, Zheng R, Li K.
Abdom Radiol (NY). 2022 Dec;47(12):4245-4253. doi: 10.1007/s00261-022-03631-0. Epub 2022 Sep 19.
[Endosonography in tumors of the pancreas and bile ducts].
Nattermann C, Dancygier H.
Leber Magen Darm. 1993 Jan;23(1):13-8, 21-3.
Carcinoid tumors of the extrahepatic bile ducts: a study of seven cases.
Maitra A, Krueger JE, Tascilar M, Offerhaus GJ, Angeles-Angeles A, Klimstra DS, Hruban RH, Albores-Saavedra J.
Am J Surg Pathol. 2000 Nov;24(11):1501-10. doi: 10.1097/00000478-200011000-00005.
Cholangiocarcinoma.
Patel T.
Nat Clin Pract Gastroenterol Hepatol. 2006 Jan;3(1):33-42. doi: 10.1038/ncpgasthep0389.
Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice.
Wang J, Dong M, Xu Z, Song X, Zhang S, Qiao Y, Che L, Gordan J, Hu K, Liu Y, Calvisi DF, Chen X.
Oncogene. 2018 Jun;37(24):3229-3242. doi: 10.1038/s41388-018-0188-1. Epub 2018 Mar 16.
